https://clinicaltrials.gov/ct2/show/NCT03840278
The Bihormonal iLet Bionic Pancreas Feasibility Study
Study Type : Interventional
Actual Enrollment : 12 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: The study follows a 2-treatment, 2-period crossover design, 2 and will consist of two 7-day study arms in random order: one bihormonal bionic pancreas arm using insulin lispro or insulin aspart and dasiglucagon, and one insulin-only bionic pancreas arm using insulin lispro or insulin aspart.
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: The Bihormonal iLet Bionic Pancreas Feasibility Study
Actual Study Start Date : May 15, 2019
Estimated Primary Completion Date : November 2019
Estimated Study Completion Date : November 2020
